12-week Open-label Evaluation of Efficacy and Safety of Indacaterol

Clinical trial NCT01232894 · COMPLETED

Trial details

NCT number: NCT01232894
Sponsor: Novartis Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease (COPD)

Start date: 2011-03-01
Primary completion: 2012-05-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.